Spotlight on remifentanil for general anaesthesia

CNS Drugs

Volumn 19, Issue 12, 2005, Pages 1069-1074

  Scott, Lesley J ^a   Perry, Caroline M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; FENTANYL; HYPNOTIC AGENT; MU OPIATE RECEPTOR AGONIST; REMIFENTANIL;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRADYCARDIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; GENERAL ANESTHESIA; HEMODYNAMICS; HOSPITAL PATIENT; HUMAN; HYPOTENSION; MUSCLE RIGIDITY; NAUSEA; OUTPATIENT; PEDIATRICS; PHARMACOLOGICAL PARAMETERS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHIVERING; SURGICAL TECHNIQUE; VOMITING;

ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; HUMANS; PIPERIDINES;

EID: 28844468910     PISSN: 11727047     EISSN: 11727047     Source Type: Journal    
DOI: 10.2165/00023210-200519120-00010     Document Type: Article

References (88)

1. Lotsch J, Angst MS. The μ-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans. Pain 2003 Mar; 102 (1-2): 151-61
2. Gustorff B, Felleiter P, Nahlik G, et al. The effect of remifentanil on the heat pain threshold in volunteers. Anesth Analg 2001 Feb; 92 (2): 369-74
3. Petersen KL, Jones B, Segredo V, et al. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers. Anesthesiology 2001 Jan; 94 (1): 15-20
4. Curatolo M, Petersen-Felix S, Gerber A, et al. Remifentanil inhibits muscular more than cutaneous pain in humans. Br J Anaesth 2000 Oct; 85 (4): 529-32
5. Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993 Nov; 77 (5): 1031-40
6. Noseir RK, Ficke DJ, Kundu A, et al. Sympathetic and vascular consequences from remifentanil in humans. Anesth Analg 2003 Jun; 96 (6): 1645-50
7. Babenco HD, Conard PF, Gross JB. The pharmacodynamic effect of a remifentanil bolus on ventilatory control. Anesthesiology 2000 Feb; 92 (2): 393-8
8. Shinohara K, Aono H, Unruh GK, et al. Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits. Can J Anaesth 2000 Apr; 47 (4): 361-6
9. Hoffman WE, Cunningham F, James MK, et al. Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide. Anesthesiology 1993 Jul; 79 (1): 107-13; discussion 26A
10. James MK, Vuong A, Grizzle MK, et al. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 1992; 263 (1): 84-91
11. Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. J Pharmacol Exp Ther 1995 Jul; 274 (1): 34-9
12. James MK, Feldman PL, Schuster SV, et al. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259 (2): 712-8
13. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet 1995 Aug; 29 (2): 80-94
14. Egan TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. Curr Opin Anaesth 2000; 13 (4): 449-55
15. Sebel PS, Hoke JF, Westmoreland C, et al. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg 1995 May; 80 (5): 990-3
16. Mason P. Remifentanil. Intensive Crit Care Nurs 2002 Dec; 18 (6): 355-7
17. Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996 Apr; 84 (4): 821-33
18. Engelhard K, Reeker W, Kochs E, et al. Effect of remifentanil on intracranial pressure and cerebral blood flow velocity in patients with head trauma. Acta Anaesthesiol Scand 2004 Apr; 48 (4): 396-9
19. Engelhard K, Werner C, Mollenberg O, et al. Effects of remifentanil/propofol in comparison with isoflurane on dynamic cerebrovascular autoregulation in humans. Acta Anaesthesiol Scand 2001 Sep; 45 (8): 971-6
20. Paris A, Scholz J, von Knobelsdorff G, et al. The effect of remifentanil on cerebral blood flow velocity. Anesth Analg 1998 Sep; 87 (3): 569-73
21. Wagner KJ, Willoch F, Kochs EF, et al. Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study. Anesthesiology 2001 May; 94 (5): 732-9
22. 2O anesthesia. Anesthesiology 1998 Aug; 89 (2): 358-63
23. Lorenz IH, Kolbitsch C, Hinteregger M, et al. Remifentanil and nitrous oxide reduce changes in cerebral blood flow velocity in the middle cerebral artery caused by pain. Br J Anaesth 2003 Mar; 90 (3): 296-9
24. Lorenz IH, Kolbitsch C, Schocke M, et al. Low-dose remifentanil increases regional cerebral blood flow and region al cerebral blood volume, but decreases regional mean transit time and regional cerebrovascular resistance in volunteers. Br J Anaesth 2000 Aug; 85 (2): 199-204
25. Baker KZ, Ostapkovich N, Sisti MB, et al. Intact cerebral blood flow reactivity during remifentanil/nitrous oxide anesthesia. J Neurosurg Anesthesiol 1997 Apr; 9 (2): 134-40
26. Lang E, Kapila A, Shlugman D, et al. Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 1996 Oct; 85 (4): 721-8
27. Olofsen E, Sleigh JW, Dahan A. The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG. Anesthesiology 2002 Mar; 96 (3): 555-64
28. Nieuwenhuijs DJ, Olofsen E, Romberg RR, et al. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index. Anesthesiology 2003 Feb; 98 (2): 312-22
29. Koitabashi T, Johansen JW, Sebel PS. Remifentanil dose/ electroencephalogram bispectral response during combined propofol/regional anesthesia. Anesth Analg 2002 Jun; 94 (6): 1530-3
30. Ropcke H, Konen-Bergmann M, Cuhls M, et al. Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth 2001 May; 13 (3): 198-207
31. Bouillon T, Bruhn J, Radu-Radulescu L, et al. Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil. Anesthesiology 2002 Dec; 97 (6): 1350-62
32. Hoke JF, Cunningham F, James MK, et al. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther 1997 Apr; 281 (1): 226-32
33. Cox EH, Langemeijer MW, Gubbens-Stibbe JM, et al. The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model. Anesthesiology 1999 Feb; 90 (2): 535-44
34. Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993 Nov; 79 (5): 881-92
35. Westmoreland CL, Hoke JF, Sebel PS, et al. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993 Nov; 79 (5): 893-903
36. Lauwers M, Camu F, Vanlersberghe C. Remifentanil, an esterase metabolised opioid: what advantages does it offer in analgesia and anaesthesia? CNS Drugs 1997; 8 (3): 189-98
37. Kan RE, Hughes SC, Rosen MA, et al. Intravenous remifentanil: placental transfer, maternal and neonatal effects. Anesthesiology 1998 Jun; 88 (6): 1467-74
38. Navapurkar VU, Archer S, Gupta SK, et al. Metabolism of remifentanil during liver transplantation. Br J Anaesth 1998 Dec; 81 (6): 881-6
39. GlaxoSmithKline UK. Ultiva injection [online]. Available from URL: http://emc.medicines.org.uk [Accessed 2005 Jul 18]
40. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995 Nov; 83 (5): 968-75
41. Dahaba AA, Oettl K, von Klobucar F, et al. End-stage renal failure reduces central clearance and prolongs the elimination half life of remifentanil. Can J Anaesth 2002 Apr; 49 (4): 369-74
42. Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997 Sep; 87 (3): 533-41
43. Dershwitz M, Rosow CE. The pharmacokinetics and pharmacodynamics of remifentanil in volunteers with severe hepatic or renal dysfunction. J Clin Anesth 1996 May; 8 (3 Suppl.): 88S-90S
44. Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996 Apr; 84 (4): 812-20
45. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997 Jan; 86 (1): 10-23
46. Russell D, Royston D, Rees PH, et al. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anaesth 1997 Oct; 79 (4): 456-9
47. Ross AK, Davis PJ, Dear GD, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 2001 Dec; 93 (6): 1393-401
48. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998 Sep; 89 (3): 562-73
49. Klemola UM, Mennander S, Saarnivaara L. Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol. Acta Anaesthesiol Scand 2000 Apr; 44 (4): 465-9
50. Alexander R, Olufolabi AJ, Booth J, et al. Dosing study of remifentanil and propofol for tracheal intubation without the use of muscle relaxants. Anaesthesia 1999 Nov; 54 (11): 1037-40
51. Alexander R, Booth J, Olufolabi AJ, et al. Comparison of remifentanil with alfentanil or suxamethonium following propofol anaesthesia for tracheal intubation. Anaesthesia 1999 Nov; 54 (11): 1032-6
52. McAtamney D, O'Hare R, Hughes D, et al. Evaluation of remifentanil for control of haemodynamic response to tracheal intubation. Anaesthesia 1998 Dec; 53 (12): 1223-7
53. Grant S, Noble S, Woods A, et al. Assessment of intubating conditions in adults after induction with propofol and varying doses of remifentanil. Br J Anaesth 1998 Oct; 81 (4): 540-3
54. Woods AW, Grant S, Harten J, et al. Tracheal intubating conditions after induction with propofol, remifentanil and lignocaine. Eur J Anaesthesiol 1998 Nov; 15 (6): 714-8
55. Stevens JB, Wheatley L. Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants. Anesth Analg 1998 Jan; 86 (1): 45-9
56. Grewal K, Samsoon G. Facilitation of laryngeal mask airway insertion: effects of remifentanil administered before induction with target-controlled propofol infusion. Anaesthesia 2001 Sep; 56 (9): 897-901
57. Salihoglu Z, Demiroluk S, Demirkiran O, et al. Comparison of effects of remifentanil, alfentanil and fentanyl on cardiovascular responses to tracheal intubation in morbidly obese patients. Eur J Anaesthesiol 2002 Feb; 19 (2): 125-8
58. Schüttler J, Albrecht S, Breivik H, et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997 Apr; 52 (4): 307-17
59. Sneyd JR, Camu F, Doenicke A, et al. Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy. Eur J Anaesthesiol 2001 Sep; 18 (9): 605-14
60. Twersky RS, Jamerson B, Warner DS, et al. Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients. J Clin Anesth 2001 Sep; 13 (6): 407-16
61. Friesen RH, Veit AS, Archibald DJ, et al. A comparison of remifentanil and fentanyl for fast track paediatric cardiac anaesthesia. Paediatr Anaesth 2003 Feb; 13 (2): 122-5
62. Davis PJ, Galinkin J, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg 2001 Dec; 93 (6): 1380-6
63. Davis PJ, Finkel JC, Orr RJ, et al. A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients. Anesth Analg 2000 Apr; 90 (4): 863-71
64. Grundmann U, Uth M, Eichner A, et al. Total intravenous anaesthesia with propofol and remifentanil in paediatric patients: a comparison with a desflurane-nitrous oxide inhalation anaesthesia. Acta Anaesthesiol Scand 1998 Aug; 42 (7): 845-50
65. Davis PJ, Lerman J, Suresh S, et al. A randomized multicenter study of remifentanil compared with alfentanil, isoflurane, or propofol in anesthetized pediatric patients undergoing elective strabismus surgery. Anesth Analg 1997 May; 84 (5): 982-9
66. Ganidagli S, Cengiz M, Baysal Z. Remifentanil vs alfentanil in the total intravenous anaesthesia for paediatric abdominal surgery. Paediatr Anaesth 2003 Oct; 13 (8): 695-700
67. Lai A, Hung CT. Effect of age on recovery from remifentanil anaesthesia. Anaesth Intensive Care 2001 Oct; 29 (5): 506-9
68. Bekker AY, Berklayd P, Osborn I, et al. The recovery of cognitive function after remifentanil-nitrous oxide anesthesia is faster than after an isoflurane-nitrous oxide-fentanyl combination in elderly patients. Anesth Analg 2000 Jul; 91 (1): 117-22
69. Song D, Whitten CW, White PF. Remifentanil infusion facilitates early recovery for obese outpatients undergoing laparoscopic cholecystectomy. Anesth Analg 2000 May; 90 (5): 1111-3
70. Dahaba AA, von Klobucar F, Rehak PH, et al. Total intravenous anesthesia with remifentanil, propofol and cisatracurium in end-stage renal failure. Can J Anaesth 1999 Jul; 46 (7): 696-700
71. Howie MB, Cheng D, Newman MF, et al. A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. Anesth Analg 2001 May; 92 (5): 1084-93
72. Geisler FE, de Lange S, Royston D, et al. Efficacy and safety of remifentanil in coronary artery bypass graft surgery: a randomized, double-blind dose comparison study. J Cardiothorac Vasc Anesth 2003 Feb; 17 (1): 60-8
73. Mollhoff T, Herregods L, Moerman A, et al. Comparative efficacy and safety of remifentanil and fentanyl in 'fast track' coronary artery bypass graft surgery: a randomized, double-blind study. Remifentanil Study Group. Br J Anaesth 2001 Nov; 87 (5): 718-26
74. Cheng DC, Newman MF, Duke P, et al. The efficacy and resource utilization of remifentanil and fentanyl in fast-track coronary artery bypass graft surgery: a prospective randomized, double-blinded controlled, multi-center trial. Anesth Analg 2001 May; 92 (5): 1094-102
75. Straka Z, Brucek P, Vanek T, et al. Routine immediate extubation for off-pump coronary artery bypass grafting without thoracic epidural analgesia. Ann Thorac Surg 2002; 74: 1544-7
76. Gelb AW, Salevsky F, Chung F, et al. Remifentanil with morphine transitional analgesia shortens neurological recovery compared to fentanyl for supratentorial craniotomy: Can J Anaesth 2003 Nov; 50 (9): 946-52
77. Balakrishnan G, Raudzens P, Samra SK, et al. A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions. Anesth Analg 2000 Jul; 91 (1): 163-9
78. Sneyd JR, Whaley A, Dimpel HL, et al. An open, randomized comparison of alfentanil, remifentanil and alfentanil followed by remifentanil in anaesthesia for craniotomy. Br J Anaesth 1998 Sep; 81 (3): 361-4
79. Guy J, Hindman BJ, Baker KZ, et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology 1997 Mar; 86 (3): 514-24
80. Chung F, Mulier JP, Scholz J, et al. A comparison of anaesthesia using remifentanil combined with either isoflurane, enflurane or propofol in patients undergoing gynaecological laparoscopy, varicose vein or arthroscopic surgery. Acta Anaesthesiol Scand 2000 Aug; 44 (7): 790-8
81. Hogue Jr CW, Bowdle TA, O'Leary C, et al. A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery. Anesth Analg 1996 Aug; 83 (2): 279-85
82. Rowbotham DJ, Peacock JE, Jones RM, et al. Comparison of remifentanil in combination with isoflurane or propofol for short-stay surgical procedures. Br J Anaesth 1998 Jun; 80 (6): 752-5
83. Wilhelm W, Grundmann U, Van Aken H, et al. A multicenter comparison of isoflurane and propofol as adjuncts to remifentanil-based anesthesia. J Clin Anesth 2000 Mar; 12 (2): 129-35
84. Cartwright DP, Kvalsvik O, Cassuto J, et al. A randomized, blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery. Anesth Analg 1997 Nov; 85 (5): 1014-9
85. Philip BK, Scuderi PE, Chung F, et al. Remifentanil compared with alfentanil for ambulatory surgery using total intravenous anesthesia: the Remifentanil/Alfentanil Outpatient TIVA Group. Anesth Analg 1997 Mar; 84 (3): 515-21
86. Hughes SC, Kan RE, Rosen MA, et al. Remifentanil: ultra-short acting opioid for obstetric anesthesia [abstract no. A894]. Anesthesiology 1996 Sep; 85 Suppl.
87. Lee MP, Kua JS, Chiu WK. The use of remifentanil to facilitate the insertion of the laryngeal mask airway. Anesth Analg 2001 Aug; 93 (2): 359-62
88. Joshi GP, Warner DS, Twersky RS, et al. A comparison of the remifentanil and fentanyl adverse effect profile in a multicenter phase IV study. J Clin Anesth 2002 Nov; 14 (7): 494-9